基于 1 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
Browse the complete record of transactions filed by Hughes Douglas J., Director. Officer active across 2 companies, notably Immunovant, Inc.. In total, 10 reports have been logged. Split: 1 buy · 2 sells. Total volume traded: €536k. History available since 27 August 2021. The latest transaction was filed on 7 April 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
Douglas J. Hughes is a Board Member at Immunovant, Inc. He brings a strategic perspective to the board, contributing to the direction and governance of the company. His diverse experience enriches discussions and decisions within the board.